tiprankstipranks
Advertisement
Advertisement

VOR Stock Latest News

Vor Biopharma Adds Industry Veteran David Zaccardelli to Board
Company AnnouncementsVor Biopharma Adds Industry Veteran David Zaccardelli to Board
9d ago
8K
VOR
Vor Biopharma shareholders back directors and governance measures
PremiumCompany Announcements
Vor Biopharma shareholders back directors and governance measures
1M ago
8K
VOR
Vor Bio gains boost from telitacicept IgA nephropathy approval
PremiumCompany Announcements
Vor Bio gains boost from telitacicept IgA nephropathy approval
1M ago
8K
VOR
Vor Bio announces China NMPA approval for telitacicept
PremiumThe Fly
Vor Bio announces China NMPA approval for telitacicept
1M ago
VOR
Vor Biopharma’s Phase 3 Sjögren’s Trial Puts Telitacicept on Investors’ Radar
PremiumCompany Announcements
Vor Biopharma’s Phase 3 Sjögren’s Trial Puts Telitacicept on Investors’ Radar
1M ago
VOR
Vor Biopharma: Buy Rating Reiterated on Strong Telitacicept Validation and Autoimmune Growth Runway; $31 Price Target Unchanged
PremiumRatingsVor Biopharma: Buy Rating Reiterated on Strong Telitacicept Validation and Autoimmune Growth Runway; $31 Price Target Unchanged
2M ago
VOR
Vor Bio price target raised to $18 from $15 at Wedbush
Premium
The Fly
Vor Bio price target raised to $18 from $15 at Wedbush
2M ago
VOR
Vor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High
Premium
Company Announcements
Vor Biopharma Advances Phase 3 Telitacicept Trial in Myasthenia Gravis, Keeping Investor Focus High
2M ago
VOR
Vor Bio files to sell 5.34M shares of common stock for holders
PremiumThe Fly
Vor Bio files to sell 5.34M shares of common stock for holders
3M ago
VOR
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
PremiumWeekend Updates
Clene, Lovesac, HDFC Bank, State Street, Vor Shock
3M ago
HDB
STT
Bj’s, Atlas, Academy, Vor, Global-e: Insider Shakeup
PremiumWeekend Updates
Bj’s, Atlas, Academy, Vor, Global-e: Insider Shakeup
3M ago
BJ
ASO
Vor Bio price target lowered to $31 from $32 at H.C. Wainwright
PremiumThe Fly
Vor Bio price target lowered to $31 from $32 at H.C. Wainwright
3M ago
VOR
Elbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
PremiumWeekend UpdatesElbit, Vor, Global-e, Sweetgreen, Immunovant: Insider Shake-Up
3M ago
SG
VOR
Vor Bio price target raised to $15 from $9 at Wedbush
Premium
The Fly
Vor Bio price target raised to $15 from $9 at Wedbush
4M ago
VOR
Vor Bio price target lowered to $40 from $55 at Stifel
Premium
The Fly
Vor Bio price target lowered to $40 from $55 at Stifel
4M ago
VOR
Vor Bio price target lowered to $40 from $55 at Stifel
PremiumThe Fly
Vor Bio price target lowered to $40 from $55 at Stifel
4M ago
VOR
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
PremiumRatings
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
4M ago
VOR
Vor Bio doses first patient in UPSTREAM SjD study
PremiumThe Fly
Vor Bio doses first patient in UPSTREAM SjD study
4M ago
VOR
Vor Bio initiated with a Buy at Jefferies
PremiumThe Fly
Vor Bio initiated with a Buy at Jefferies
4M ago
VOR
Vor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating
PremiumRatingsVor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating
4M ago
VOR
Vor Biopharma Announces $75 Million Private Placement Financing
Premium
Company Announcements
Vor Biopharma Announces $75 Million Private Placement Financing
4M ago
8K
VOR
Vor Bio to sell 5.338M shares at $14.05 in private placement
Premium
The Fly
Vor Bio to sell 5.338M shares at $14.05 in private placement
4M ago
VOR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >